The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...
Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe. He will oversee Kenvue’s business in the ...
Varenicline works by reducing cravings for nicotine and blocking its effect on ... Champix and another oral smoking cessation therapy, GSK's Zyban (bupropion), saw restrictions placed on their ...
ADVICOR prolonged-release tablet 20 mg+1 000 mg AbbVie Inc. ADVICOR prolonged-release tablet 20 mg+500 mg AbbVie Inc. ADVICOR prolonged-release tablet 20 mg+750 mg AbbVie Inc. ADVICOR ...
McNeil AB), nicotine lozenge 2 mg and nicotine lozenge 4 mg (NiQuitin Lozenge 2 and 4 mg, GlaxoSmithKline, Copenhagen, Denmark). The doses selected were based on the currently recommended single doses ...
We identified patients with COPD who received a prescription of nicotine replacement therapy (NRT ... RW received grants, personal fees and non-financial support from Pfizer, GSK and J&J and personal ...
The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...
LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...
It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...
GSK's revenue and EPS exceeded my expectations and those of analysts, thanks to the strong performance of its oncology and HIV franchises. So, Ojjaara/Omjjara sales amounted to $150 million in the ...
CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 ...